| Cys-27 variant of human delta-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization. Leskela T.T., Lackman J.J., Vierimaa M.M., Kobayashi H., Bouvier M., Petaja-Repo U.E.
J. Biol. Chem. 287:5008-5020(2012) · Mapped (2) |
| Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Sarajarvi T., Tuusa J.T., Haapasalo A., Lackman J.J., Sormunen R., Helisalmi S., Roehr J.T., Parrado A.R., Makinen P., Bertram L. et al.
Mol. Cell. Biol. 31:2326-2340(2011) · Mapped (12) |
| Phe27Cys polymorphism of the human delta opioid receptor predisposes cells to compromised calcium signaling. Tuusa J.T., Petaja-Repo U.E.
Mol. Cell. Biochem. 351:173-181(2011) · Mapped (2) |
| Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction. Hakalahti A.E., Tapanainen J.M., Junttila J.M., Kaikkonen K.S., Huikuri H.V., Petaja-Repo U.E.
Cardiovasc Diabetol 9:42-42(2010) · Mapped (4) |
| Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage. Hakalahti A.E., Vierimaa M.M., Lilja M.K., Kumpula E.P., Tuusa J.T., Petaja-Repo U.E.
J. Biol. Chem. 285:28850-28861(2010) · Mapped (4) |
| Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin. Tuusa J.T., Leskela T.T., Petaja-Repo U.E.
FEBS J. 277:2815-2829(2010) · Mapped (6) |
| Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor. Leskela T.T., Markkanen P.M., Alahuhta I.A., Tuusa J.T., Petaja-Repo U.E.
Traffic 10:116-129(2009) · Mapped (2) |
| N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface. Markkanen P.M., Petaja-Repo U.E.
J. Biol. Chem. 283:29086-29098(2008) · Mapped (2) |
| The endoplasmic reticulum Ca2+-pump SERCA2b interacts with G protein-coupled receptors and enhances their expression at the cell surface. Tuusa J.T., Markkanen P.M., Apaja P.M., Hakalahti A.E., Petaja-Repo U.E.
J. Mol. Biol. 371:622-638(2007) · Mapped (13) |
| Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. Leskela T.T., Markkanen P.M., Pietila E.M., Tuusa J.T., Petaja-Repo U.E.
J. Biol. Chem. 282:23171-23183(2007) · Mapped (2) |
| Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum. Apaja P.M., Tuusa J.T., Pietila E.M., Rajaniemi H.J., Petaja-Repo U.E.
Mol. Biol. Cell 17:2243-2255(2006) · Mapped (5) |
| Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface. Pietila E.M., Tuusa J.T., Apaja P.M., Aatsinki J.T., Hakalahti A.E., Rajaniemi H.J., Petaja-Repo U.E.
J. Biol. Chem. 280:26622-26629(2005) · Mapped (5) |
| Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. Apaja P.M., Harju K.T., Aatsinki J.T., Petaja-Repo U.E., Rajaniemi H.J.
J. Biol. Chem. 279:1899-1906(2004) · Mapped (5) |
| Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Morello J.P., Salahpour A., Petaja-Repo U.E., Laperriere A., Lonergan M., Arthus M.F., Nabi I.R., Bichet D.G., Bouvier M.
Biochemistry 40:6766-6775(2001) · Mapped (4) |
